140 related articles for article (PubMed ID: 23026382)
1. Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy.
Rose J; Wertheim BC; Guerrero MA
Am J Surg; 2012 Dec; 204(6):881-6; discussion 886-7. PubMed ID: 23026382
[TBL] [Abstract][Full Text] [Related]
2. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
[TBL] [Abstract][Full Text] [Related]
3. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
4. Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy.
Haddy N; Andriamboavonjy T; Paoletti C; Dondon MG; Mousannif A; Shamsaldin A; Doyon F; Labbé M; Robert C; Avril MF; Fragu P; Eschwege F; Chavaudra J; Schvartz C; Lefkopoulos D; Schlumberger M; Diallo I; de Vathaire F
Radiother Oncol; 2009 Nov; 93(2):377-82. PubMed ID: 19515442
[TBL] [Abstract][Full Text] [Related]
5. Pediatric solid tumors and second malignancies: characteristics and survival outcomes.
Vasudevan V; Cheung MC; Yang R; Zhuge Y; Fischer AC; Koniaris LG; Sola JE
J Surg Res; 2010 May; 160(2):184-9. PubMed ID: 19765728
[TBL] [Abstract][Full Text] [Related]
6. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.
Wright JD; St Clair CM; Deutsch I; Burke WM; Gorrochurn P; Sun X; Herzog TJ
Cancer; 2010 May; 116(10):2486-92. PubMed ID: 20209618
[TBL] [Abstract][Full Text] [Related]
7. The risk of multiple primary breast and thyroid carcinomas.
Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
[TBL] [Abstract][Full Text] [Related]
9. Thyroid adenomas after solid cancer in childhood.
Haddy N; El-Fayech C; Guibout C; Adjadj E; Thomas-Teinturier C; Oberlin O; Veres C; Pacquement H; Jackson A; Munzer M; N'Guyen TD; Bondiau PY; Berchery D; Laprie A; Bridier A; Lefkopoulos D; Schlumberger M; Rubino C; Diallo I; de Vathaire F
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e209-15. PubMed ID: 22672756
[TBL] [Abstract][Full Text] [Related]
10. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
Zacharatou Jarlskog C; Paganetti H
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
[TBL] [Abstract][Full Text] [Related]
11. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
12. Second tumors in pediatric patients treated with radiotherapy to the central nervous system.
Galloway TJ; Indelicato DJ; Amdur RJ; Swanson EL; Smith AA; Marcus RB
Am J Clin Oncol; 2012 Jun; 35(3):279-83. PubMed ID: 21383606
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second malignancies among patients treated with proton versus photon radiation.
Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
[TBL] [Abstract][Full Text] [Related]
14. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
16. Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.
Sultan I; Rihani R; Hazin R; Rodriguez-Galindo C
Acta Oncol; 2010; 49(2):237-44. PubMed ID: 20100158
[TBL] [Abstract][Full Text] [Related]
17. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
18. Risk of thyroid cancer after exposure to 131I in childhood.
Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
[TBL] [Abstract][Full Text] [Related]
19. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
